Along with warmer temperatures and the beautiful blossoming across the city, spring has become synonymous with the Philadelphia Science Festival, a staple and model for similar initiatives in other cities, that continues to grow each year.
Wistar investigators receive support through the Commonwealth Universal Research Enhancement Program (CURE), which funds health research across Pennsylvania. Each year in early May, representatives from Wistar and fellow institutions who are part of the Pennsylvania Cancer Alliance engage legislators to reinforce the importance and impact of CURE funding.
For two decades, Wistar’s Biomedical Technician Training (BTT) pre-apprenticeship program has injected biomedical talent into the region’s life sciences workforce by ushering class after class of promising Community College of Philadelphia (CCP) students to attain the skills and experience required to become part of a growing biomedical science workforce.
Wistar scientists created synthetic DNA-encoded Antibodies (DMAbs) against the Zika virus, shed light on how myeloid-derived suppressor cells are crucial for the regulation of immune responses to cancer and developed a new DNA-based immunotherapeutic technology that was effective in preclinical models of cancer.